Extrachromosomal DNA in urothelial carcinoma: mechanisms and clinical applications.
This publication is a focused review on the role of extrachromosomal DNA (ecDNA) in urothelial carcinoma. Key points:...
Management of surgical menopause in female patients with bladder cancer undergoing radical cystectomy.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:2 mins read
This publication is a narrative review focused on surgical menopause in women undergoing radical cystectomy for bladder...
Disitamab vedotin (RC48-ADC) combined with immunotherapy as neoadjuvant therapy for localized muscle-invasive bladder cancer: a multicenter real-world study.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:2 mins read
This multicenter retrospective real-world study evaluated neoadjuvant disitamab vedotin (RC48), a HER2-directed antibody...
Optimizing local control in the surgical management of bladder cancer.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
The publication reviews the evolving treatment landscape for localized muscle-invasive bladder cancer. Traditionally man...
Multi-institutional validation of AI models for classifying urothelial neoplasms in digital pathology.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
This study presents a deep learning approach using convolutional neural networks and transformer-based models to classif...
Inlexzo (gemcitabine intravesical system): promising data but key questions remain.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
The FDA approval of Inlexzo (gemcitabine intravesical system) marks a significant advance in bladder-sparing treatment f...